Sebastian Bernales

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Matthew L. Wein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sebastian Bernales:

Company Role Class Num Shares Value Price $ Report Date Ownership
Metagenomi, Inc. Director Common Stock 1,896,445 $5,461,762 $2.88 13 Feb 2024 By Humboldt Fund I, LP
Metagenomi, Inc. Director Common Stock 402,496 $1,159,188 $2.88 13 Feb 2024 By Praxis Biotech LLC
Metagenomi, Inc. Director Common Stockc 769,845 13 Feb 2024 Direct
Metagenomi, Inc. Director Stock Option (Right to Buy) 78,636 01 Apr 2024 Direct
Metagenomi, Inc. Director Series A-2 Preferred Stock 0 13 Feb 2024 Direct
Metagenomi, Inc. Director Series A-3 Preferred Stock 0 13 Feb 2024 Direct
Metagenomi, Inc. Director Series A-4 Preferred Stock 0 13 Feb 2024 By Humboldt Fund I, LP
Metagenomi, Inc. Director Series A-4 Preferred Stock 0 13 Feb 2024 Direct
Metagenomi, Inc. Director Series B-1 Preferred Stock 0 13 Feb 2024 By Humboldt Fund I, LP
Metagenomi, Inc. Director Series B Preferred Stock 0 13 Feb 2024 By Humboldt Fund I, LP

Insider Reports Filed by Sebastian Bernales

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MGX Metagenomi, Inc. 01 Apr 2024 1 $0 4 Director 03 Apr 2024, 20:44
MGX Metagenomi, Inc. 13 Feb 2024 8 $0 4 Director 14 Feb 2024, 16:29
MGX Metagenomi Technologies, LLC 08 Feb 2024 0 $0 3 Director 08 Feb 2024, 19:24